uniQure N.V.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
37.14 M
Public Float
-
uniQure N.V.
Stock Exchange NASDAQ Stock Market
EPS
$2.48
Market Cap
$2.85 B
Shares Outstanding
37.63 M
Public Float
20.95 M

Profile

Address
Paasheuvelweg 25a
Amsterdam Noord-Holland 1105 BP
Netherlands
Employees -
Website http://www.uniqure.com
Updated 07/08/2019
uniQure NV engages in the research, development, and commercialization of gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded on January 9, 2012 and is headquartered in Amsterdam, the Netherlands.

Financials

View All
Created with Highcharts 5.0.14uniQure N.V.Net Income. Fiscal year is January-December. All values USD Thousands.35 60635 60649 13149 13179 26579 26573 37473 37479 26079 26083 30483 304201320142015201620172018020k40k60k80k100k
Created with Highcharts 5.0.14uniQure N.V.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.3 9073 9076 2146 21410 45110 45125 09825 09813 10713 10711 28411 28420132014201520162017201805k10k15k20k25k30k

Matthew C. Kapusta
Director, Chief Executive & Financial Officer
David D. Meek
Director